SCHEMBL10815169

SCHEMBL10815169

CCCCCCCCCCOC(=O)OCCCOC(OC(=O)OCCCCCCCCCC)n1cnc2c(SC)nc(N(C)C)nc21

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.31
▸ CYP1A2 P05177 1/20 0.30
▸ TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10814393 0.88 HK1 (0.39) ALDH1A1
SCHEMBL10816337 0.85 CYP1A2 (0.43) ALDH1A1CYP1A2TSHR
SCHEMBL10815175 0.79 PDE3A (0.35) ALDH1A1CYP1A2TSHR
SCHEMBL10813165 0.77 PDE3A (0.41) ALDH1A1CYP1A2TSHR
SCHEMBL10540197 0.72 CDK2 (0.36) CYP1A2TSHR
SCHEMBL10817431 0.71 ADA (0.47) ALDH1A1CYP1A2TSHR
SCHEMBL9584672 0.70 ALDH1A1 (0.38) ALDH1A1CYP1A2TSHR
SCHEMBL10815977 0.69 CDK5 (0.35) —
SCHEMBL10818088 0.69 CDC20 (0.35) —
SCHEMBL9583624 0.68 CYP1A2 (0.40) CYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0105135-B1 SUBSTITUTED 9-(1-0- OR 3-0-MONOSUBSTITUTED OR 1,3-DI-0-SUBSTITUTED 1,3 DIHYDROXY-2-PROPOXYMETHYL) PURINES AS ANTIVIRAL AGENTS SYNTEX (U.S.A.) INC. (US) 1987-03-18 — — EP disclosed
US-4609661-A HERPES VIRUS SYNTEX (U.S.A.) INC. (US) 1986-09-02 — — US disclosed
US-4556659-A Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents SYNTEX (U.S.A.) INC. (US) 1985-12-03 — — US disclosed
EP-0105135-A1 Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-di-0-substituted 1,3 dihydroxy-2-propoxymethyl) purines as antiviral agents SYNTEX (U.S.A.) INC. (US) 1984-04-11 — — EP disclosed
Send feedback